ARISTA™ Antigen Rapid Test Kit is a CE-certified antigen rapid test to aid the early detection and diagnosis of COVID-19 novel coronavirus.
This early detection kit can be effectively tested for asymptomatic or symptomatic patients, providing easy-to-read results in 15 minutes.
Different from blood drop antibody tests, which are more effective for detection seven to ten days after infection, this antigen test is appropriate for early infection test as early as 3 days after infection.
Intended for in vitro qualitative detection of the SARS-CoV-2 virus nucleocapsid (N) protein antigen in deep throat sputum, oropharyngeal, nasal and nasopharyngeal swab specimens.
Developed and made in Singapore, this product is recognized by the WHO and fully complies with ISO and EU standards.
This test kit is designed for primary screening only. If you have any doubts about the test results, seek medical advise immediately. The Test result should be used in conjunction with other clinical information to diagnose COVID-19 infection. If you are suspecting an infection, feeling unwell or have any symptoms such as fever, cough, runny nose, sore throat, you should consult medical professionals immediately for the confirmation of diagnosis. Read More
- Up to 90% Sensitivity
- Early Detection
- Results in 15 min
- Recognized by WHO
- Easy to Use
|Type||Lateral Flow Detection (LFD) In-vitro Qualitative Detection|
|Specimen||(A) Deep throat sputum/saliva (Recommended) or (B) Nasopharyngeal Swab or (C) Oropharyngeal Swab|
|Reusable||No (Single-Time Use)|
|Sensitivity||Consistency with RT-PCR Tests: 95.3%
|Result Time||15 minutes|
|Detection||SARS-CoV-2 Virus Nucleocapsid (N) Protein Antigen|